Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 -2.91%59 Median PS Value is 円177.13 as of Jul. 17, 2026, which is 100% below its 10-year median of 0.96. GuruFocus rates TSE:6029 with a GF Score™ of 59/100 and a GF Value™ of 円140.45 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 262 Healthcare Providers & Services companies, Artra Group ranks worse than 80.15% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Artra Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円182.529. Artra Group's 10-Year median PS Ratio is 0.9704. Therefore, the Median PS Value for today is 円177.13.
As of today (2026-07-17), Artra Group's share price is 円200.00. Artra Group's Median PS Value is 円177.13. Therefore, Artra Group's Price to Median PS Value for today is 1.13.
The historical rank and industry rank for Artra Group's Median PS Value or its related term are showing as below:
TSE:6029'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.96 Med: 0.96 Max: 1.16
Current: 1.13
During the past 13 years, the highest Price to Median PS Value of Artra Group was 1.16. The lowest was 0.96. And the median was 0.96.
TSE:6029's Price-to-Median-PS-Value is ranked worse than 80.15% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs TSE:6029: 1.13
Artra Group (TSE:6029) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Artra Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
200.00
/
177.13
=
1.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group Median PS Value Related Terms
Artra Group Median PS Value Historical Data
* Premium members only.
The historical data trend for Artra Group's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Artra Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Artra Group's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.9704.
Artra Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円182.529.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group (TSE:6029) has a Median PS Value of 円177.13 as of Jul. 17, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Artra Group and its competitors. This is 18351% above median its historical median of 0.96. Over the past decade, Artra Group's Median PS Value has ranged from 0.96 to 1.16. According to the industry distribution chart, Artra Group ranks #210 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 80.2%.
Is Artra Group's Median PS Value too high?
Artra Group's current Median PS Value of 円177.13 is 18351% above median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 1.16. Based on the distribution chart, Artra Group ranks #210 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Artra Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #210 out of 262 companies for Median PS Value. This places Artra Group in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, Artra Group's own Median PS Value has ranged from 0.96 to 1.16 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Median PS Value is 円177.13, which is 18351% above median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円140.45, compared to a current price of 円200.00 — trading 42.4% above its estimated fair value. The current Median PS Value is 円177.13, which is 18351% above median its 10-year median of 0.96. Artra Group's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Median PS Value is 円177.13 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円200.00 is trading 42.4% above its estimated GF Value™ of 円140.45.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Median PS Value: 円177.13 (18351% above median its 10-year median of 0.96)
GF Value™: 円140.45 vs. price of 円200.00 (42.4% above fair value)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
59GF Score
Get the complete analysis for TSE:6029
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
